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Summary A new in vitro model has been developed for investigating extravascular diffusion of therapeutic agents in tumour tissue. V79-
171b or EMT6/Ak cells are grown on porous Teflon support membranes and submerged in a large reservoir of medium, to give diffusion-
limited 'multicellular membranes' (MMs) c. 200gm in thickness. MMs are histologically similarto multicellular spheroids, buttheirplanar rather
than spherical geometry facilitates direct measurement ofthe flux of radiolabelled agentsthrough the multicellular structure. For[14C]urea, flux
kinetics through V79-171b MMs was modelled as simple diffusion, yielding a diffusion coefficient in the MM (DMM) of 1.45 x 106 cm2 S-1, 11-
fold lower than in culture medium. Flux of the 3H-labelled DNA intercalator 9-[3-(N,N-dimethylamino)propylamino]acridine (DAPA) was
dramatically slower than urea. Modelling this over the first 5 h gave a DMM of 1.3 x 10- cm2 s-1, but over longer times the kinetics was not
consistent with simple diffusion. Flux of DAPA was markedly increased in the presence of 50 mm ammonium chloride, indicating that
sequestration in acidic endosomes is a major impediment to flux. Accumulation in cytoplasmic vesicles was confirmed by fluorescence
microscopy. The DAPA flux kinetics, with and without ammonium chloride, was well fitted by a reaction-diffusion model with reversible cellular
uptake (modelled as binding), using uptake parameters determined in separate experiments with V79-171b single-cell suspensions. This
study demonstrates the utility of the MM model for determining extravascular transport parameters, and indicates that much of the
impediment to diffusion of basic DNA intercalators in tumour tissue may arise from lysosomal sequestration rather than DNA binding.
Keywords: Multicellular membrane; extravascular diffusion; DNA binding drug; 9-[3-(N,N-dimethylamino)propylamino]acridine;
lysosomotropic base
Success in cancer chemotherapy is dependent on exposure of
target cells to effective concentrations of drugs. However, solid
tumours have an inefficient blood supply that may compromise
delivery of therapeutic agents, particularly to cells distant from
functional vessels (Jain, 1987; Durand, 1989; Jain and Baxter,
1993). The presumed drug delivery problem has three main
components. First, high interstitial pressures and other factors can
lead to low blood flows in exchange vessels in some regions of
tumours, thus compromising drug delivery (Jain and Baxter,
1993). Second, the spatially disorganized microvasculature in
tumours necessitates extravascular diffusion of therapeutic agents
over long distances relative to those in normal tissue (Vaupel et al,
1989). Third, for some classes of cytotoxic drugs, even of low
molecular weight, diffusion in the extravascular compartment will
probably be slow. For example, DNA intercalators bind to recep-
tors (interbase pair sites in DNA) present in high concentration in
tissue. As only the free drug contributes to the driving force for
diffusion, any such binding will severely impede extravascular
transport; simple calculations suggest that for typical DNA
intercalators diffusion times in the order of many hours may be
required before the concentration at a distance of 100 gm from a
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vessel reaches 90% of that in plasma (Wilson and Denny, 1992).
Although a steady-state distribution would eventually be achieved,
the available equilibration time is constrained by clearance from
plasma. This problem may be partly offset by slow efflux from the
tumour (Durand, 1990; Baguley and Finlay, 1995), but is expected
to compromise severely delivery to cells distant from vessels.
Further, drug metabolism in the extravascular compartment can
preclude access of drugs to these cells, even under steady-state
conditions, as illustrated by the failure of bioreductive drugs to
reach the centre of spheroids if the rate of metabolism in the
periphery is too high (Wilson et al, 1986; Durand and Olive, 1992).
In addition to these factors, it is particularly important in cancer
therapy to eliminate all clonogenic cells, and the treatment
outcome is therefore vulnerable to underdosing ofa small fraction
of the tumour. Thus, inefficient extravascular drug diffusion
will probably have more important consequences in cancer
chemotherapy than in pharmacological contexts in which the
objective is to elicit or modify a physiological response. For all
these reasons, the assumption implicit in most pharmacodynamic
models that equilibrium between drug in the plasma and receptor
(target) compartments is achieved rapidly, and that extravascular
diffusion is therefore not a limiting factor in drug action, is suspect
in the context ofcancer therapy.
Although thepotential problem ofdelivering therapeutic agents to
their target cells in solid tumours is widely acknowledged, there is
little direct information on the extent to which it contributes to treat-
mentfailure in cancerchemotherapy. There are many tumour-related
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Figure 1 (A) Cell culture insert modified for growth of MM by floating on, or submerging in, a well-stirred reservoir of culture medium (CM). (B) Apparatus for
drug flux experiments: 1, compartment into which drug is introduced; 2, compartment in which drug concentration is determined as a function of time
and drug-related factors that will determine the magnitude of any
extravascular diffusion problem, thus making prediction difficult.
With the exception of antibodies, for which low diffusion coeffi-
cients and binding to tissue antigens can result in severe extra-
vascular transport problems (Jain and Baxter, 1988), little use has
been made ofdistributed parameter mathematical models in which
spatial concentration gradients of the diffusant are treated explic-
itly. A major limitation in this regard is the lack of experimental
systems in which transport parameters (e.g. effective diffusion
coefficient, kinetics of binding and metabolism in tissue) can be
measured directly. The extravascular diffusion of dextrans,
albumin and antibodies has been measured in window prepara-
tions of tumours (Clauss and Jain, 1990), but such systems are
generally only applicable to fluorescent or phosphorescent agents
and are not readily amenable to experimental manipulation.
Multicellular spheroids have provided a useful tissue culture
model for the extravascular compartment of tumours (Sutherland,
1988), and have demonstrated that diffusion of some drugs is
severely compromised. These studies have used fluorescence
microscopy (Kerr and Kaye, 1987) or autoradiography (Nederman
et al, 1981) to visualize concentration gradients of diffusants, or
have inferred the existence of diffusion limitations because of the
lack of drug response of the innermost cells (Wilson et al, 1981;
Olive, 1986; Kwok and Twentyman, 1987; Durand, 1989).
However, direct measurement of diffusion rates has proved
difficult with these methods (Groebe et al, 1994), and quantitative
diffusion parameters for cytotoxic drugs have not been obtained.
We have described recently (Cowan et al, 1996) a new in vitro
model for the extravascular compartment of tumours that over-
comes many of the limitations of spheroids for drug diffusion
studies. In this model, tumour cells are grown as a multicellular
membrane (MM) on a commercially available permeable support
submerged in alarge reservoir ofculture medium (Figure IA). MMs
are diffusion-limited structures that resemble spheroids, but with the
advantage that flux can be measured directly by adding the agent of
interest to one side ofthe MM and sampling the other side as a func-
tion of time. The present study describes the mathematical model-
ling of flux data to derive transport parameters, and uses MMs to
quantitate diffusion of a 9-aminoacridine derivative, DAPA (9-[3-
(N,N-dimethylamino)propylamino]acridine; Figure 2). DAPA can
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be considered broadly representative of basic DNA binding anti-
cancer drugs, and is closely related to the topoisomerase inhibitor
DACA (N-[2-(diethylamino)ethyl]acridine-4-carboxamide) that is
currently in phase I clinical trial. DAPA was chosen as a model
DNA intercalator because it is fluorescent, relatively non-cyto-
toxic (Roberts et al, 1990), and can be readily prepared in radiola-
belled form. In addition, preliminary studies demonstrated its
stability in high cell density cultures, suggesting that the compli-
cating effects of drug metabolism could be avoided in this initial
study.
MATERIALS AND METHODS
Chemicals and radiochemicals
D-[6-3H]glucose (1.1 TBq mmol-1) and ['4C]urea (185 MBq
mmol-') were purchased from NEN Research Products, Boston,
MA, USA. DAPA was synthesized as described previously
(Ledochowski et al, 1964). [3H]DAPA (dihydrochloride salt, sp.
act. 14.9 GBq mmol-') was synthesized similarly from the sodium
salt ofN-phenylanthranilic acid that was randomly tritiated in the
aromatic rings by catalytic 3H exchange (Amersham, Bucks, UK).
[3H]DAPA was repurified to >99% radiochemical purity before
use by dissolving in water to 5 mm and separating from the
acridone impurity by high-performance liquid chromatography
(HPLC) (see below).
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Preparation of multicellular membranes
The Teflon microporous membranes (Biopore) of Millipore CM
cell culture inserts (Millipore, Bedford, MA, USA) were coated
with collagen to allow cell attachment. One volume of a solution
(3 mg ml-') of acid-soluble calf skin collagen (type III, Sigma
Chemical, St Louis, MO, USA) in 0.01 N hydrochloric acid was
mixed with four volumes of 60% ethanol and 0.1-ml aliquots
added to the culture inserts. These were allowed to dry and a
sterile ring of expanded polyethylene was added to allow subse-
quent flotation. V79-171b Chinese hamster fibroblasts or
EMT6/Ak cells (2 x 105 cells) were seeded onto the collagen-
coated inserts in 0.5 ml ofmedium (a-MEM containing 10% fetal
bovine serum, 100 IU ml-1 penicillin and 100 jg ml-' strepto-
mycin). Inserts were incubated in a 5% carbon dioxide incubator
for 4-6 h to allow cell attachment and were then submerged
beneath a wide-mesh stainless steel grid in ajar containing a large
reservoir of medium (60 ml per insert, stirred magnetically in a
37°C waterbath). Single-cell suspensions were prepared from the
resulting MM by incubating in culture medium containing pronase
(0.5 mg ml-') and DNAase (0.2 mg ml-') for 20 min at 37°C with
magnetic stirring.
Thickness of multicellular membranes
Frozen sections were prepared by cutting the support membrane
from the walls of the insert with a scalpel and transferring to
Tissue Tek OCTembedding compound (Miles, Elkhart, IN, USA),
freezing rapidly with Freon and transferring to liquid nitrogen.
Transverse sections (10 jm thickness) were cut at intervals of
1 mm across the membrane and the thickness determined at inter-
vals of 40 jm along each section at 100 x magnification using a
calibrated ocular graticule. Measurements were corrected for any
lack oforthogonality ofsections by scoring the apparent thickness
of the Biopore support membrane at each point, using a nominal
thickness of30 jm (which was the minimum value observed).
Drug diffusion experiments
Culture inserts containing MM were placed in a Petri dish. The
integrity and uniformity ofthe MM were examined with an inverted
phase-contrast microscope and by testing that medium did not flow
out of the insert. Suitable inserts were floated in bottles containing
18 ml of medium with 20 mm Hepes (compartment 2), with
magnetic stirring of the latter compartment in a 37°C waterbath
(Figure 1B). The bottle and lid were submerged below the surface of
the water throughout the experiment to maintain strict temperature
uniformity, thus minimizing convective disturbance. Thefluxexper-
iment was initiated by adding 50jl ofmediumcontaining theradio-
labelled agent(s) to the insert (compartment 1), using a Hamilton
syringe, via a stainless-steel tube (i.d. 0.5 mm) fixed through the lid.
This was mixed quickly by pumping with the syringe and 50 jl was
removed for scintillation counting to determine concentration at
zero time (c,) and hence compartment 1 volume and diffusion path
length. A second tube, fixed in the lid, allowed repetitive sampling
of compartment 2, without disturbing the insert, for scintillation
counting orHPLC. In amodification ofthis method, afterinspection
of MM as above, compartment 1 was replaced with medium
(0.5 ml) containing agar (usually 0.5%), 20 mm Hepes and the
radiolabelled substances. The insert was then floated in the pre-
equilibrated flux bottle to initiate the flux experiment.
Measurement of [3H]DAPA by HPLC
Samples of medium containing [3H]DAPA were analysed by
HPLC using a refrigerated (4°C) autoinjector, a Waters
jiBondapak C,8 column (Millipore, Milford, MA, USA), and a
diode array detector (Hewlett Packard 1040A, signal 266 nm,
bandwidth 4 nm). The mobile phase comprised a linear gradient of
10-50% acetonitrile in 0.45 M ammonium formate, pH 4.5, at a
flow rate of 1.8 ml min-'. Fractions (1 ml) of the eluate were
collected and radioactivity determined off-line by scintillation
counting using a water-accepting scintillant.
DAPA uptake by single cells
Single-cell suspensions were prepared from V79-171b MM and
uptake of [3H]DAPA was examined using the spin-through-oil
method (Vistica, 1979). The pH of the medium was adjusted by
adding 12 N hydrochloric acid and gassing with 5% carbon dioxide
at 37°C for at least 1 h to ensure that equilibrium had been
attained. Magnetically stirred cell suspensions (5 x 105 cells ml-')
in medium were equilibrated for 30 min, incubated with
[3H]DAPA under 5% carbon dioxide, and samples (1 ml) were
withdrawn at intervals and centrifuged (13 000 g, 1 min) at 20°C
through 0.3 ml of a 1:1 (v/v) mixture ofDow Coming 550 and 556
silicone oils (Serva Feinbiochemical, Heidelberg, Germany).
Radioactivity in extracellular medium was determined by counting
the supernatant (100 jl) in a water-accepting scintillant. After
aspiration ofthe remaining medium and oil, cell pellets were solu-
bilized with 1 ml ofNCS II tissue solubilizer (Amersham, Ontario,
Canada) and counted in organic scintillant. Subcellular localiza-
tion of non-radioactive DAPA was examined with an epifluores-
cence microscope (Nikon Optiphot, excitation 405-430 nm,
barrier filter 435 nm). Log-phase V79-171b cells grown on glass
coverslips were exposed to DAPA in culture medium at 37°C for
10 min and photographed immediately after inverting onto glass
slides.
RESULTS
Application of MM to measurement of drug diffusion
V79-171b or EMT6/Ak cells gave steady state MMs containing
c. 6 x 106 cells between 4 and 7 days after seeding the Teflon
support membranes with 2 x 10 cells. These MM were relatively
uniform (especially with V79-171b cells) and symmetrical, with
central necrosis developing on day 4 or 5. The distribution of
thickness in three V79-171b MM, grown for 4 days and examined
systematically using frozen transverse sections, is shown in Figure
3. The growth of V79-171b cells as a uniform and continuous
barrier between two medium compartments indicated the suit-
ability ofthese MM for flux studies.
A simulation was performed (using the diffusion equations
described in Appendix 1) to assess the sensitivity of net flux to the
effective diffusion coefficient in the MM (DMM) under the flux
conditions employed (compartment 1 unstirred after addition of
diffusant, and compartment 2 well stirred), assuming an MM
thickness of 200 jim and a path length corresponding to 0.5 ml in
compartment 1 (Figure 4A). This showed that initial flux is appre-
ciably lowered if the DMM is 10% of the diffusion coefficient in
compartment 1 (D,). Further, the Teflon support membrane (thick-
ness 30 jm) will have little effect on the observed flux, especially
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Figure 3 Histograms showing the distribution of thicknesses of three individual V79-171 b multicellular membranes (MM), after growing submerged for 4 days,
as measured by systematic sampling across multiple frozen sections (see Materials and methods)
when DMM is low, even if the effective porosity of the support
membrane (DS/D1, where Ds is the diffusion coefficient in the
support membrane) is only 7.3% as assumed in this simulation
(see below).
Convective disturbance and support membrane
porosity
Flux of [14C]urea was examined using collagen-coated support
membranes without cells. In initial experiments the flux kinetics
was faster than could be accounted for by diffusion, even
assuming a porosity of 100% for the support membrane (i.e. DS =
D,), indicating convective disturbance in compartment 1. This
problem was minimized by submerging the flux apparatus in a
37°C waterbath throughout the experiment to prevent temperature
gradients. Flux of [14C]urea through collagen-coated support
membranes in the absence ofcells (Figure 4B) was then modelled
well as diffusion without convection, usingD, = 1.6 x 10-5 cm2 s-1
which is derived from the literature value for urea in water at 25°C
(Cussler, 1984) using the Stokes-Einstein equation to extrapolate
to 37°C. Addition ofagar (up to 2%) to compartment 1 at the same
time as the urea did not alter the flux kinetics appreciably (Figure
4B). Agar was used at 0.5% in most subsequent experiments as a
further protection against convection.
For modelling the above urea flux in the absence of cells, the
fitted parameter was the effective porosity of the support
membrane. The fitted porosity was 7.3 ± 1.6 % (s.e.m., n = 10);
this value was used in all subsequent modelling. Similar experi-
ments with [3H]glucose were in good agreement (porosity 7.0 ±
0.9%, n = 5), using a diffusion coefficient of 9 x 10 cm2 s-' in
water at 37°C (Jain, 1987). These porosity estimates include the
effect of the unstirred boundary layer between the support
membrane and compartment 2.
Diffusion of urea through V79-171b and EMT6
multicellular membranes
The diffusion of ['4C]urea (cl 0 250 gM) was slowed by the pres-
ence of V79-171b MM (Figure 4B). The flux data showed good
reproducibility between different MMs, and were fitted well by a
simple diffusion model. The effective diffusion coefficient in the
cellular layer (DMM) was (1.45 ± 0.10) x 10- cm2 S-1 (mean +
s.e.m., n = 9), i.e. 11-fold lower than in medium (compartment 1),
based on the mean thicknesses of each MM as determined from
frozen sections after the flux experiments. Similar experiments
were performed with EMT6/Ak MMs, which were grown by
floating on the medium reservoir for 4 days after seeding 5 x 104-
2 x 105 cells. Urea flux was determined, without addition of agar,
over 2 h. Frozen sections, determined after the flux experiments,
showed the individual MM to vary in mean thickness from 173
to 292 jim. Using thickness estimates from frozen sections
(means from 173 to 292 ,um), the urea flux data gave a DMM of
(1.97±0.13)x xlOcm2s-' (n=5).
Diffusion of [3H]DAPA through V79-171b MM
The diffusion coefficient of the DNA intercalator DAPA in
medium (cl 0 25 ,UM) was determined from the flux through
Biopore support membranes without cells, using agar in compart-
ment 1, as illustrated in Figure 5. The measured value was
(3.87 ± 0.28) x 10-6 cm2 s-' (n = 9); this estimate averages values
for 0.5, 1 and 2% agar, which were not significantly different.
Diffusion of DAPA through V79-171b MM was investigated in a
similar manner. Despite the use of [3H]DAPA of very high radio-
chemical purity (> 99%), a high proportion of the radioactivity in
compartment 2 corresponded to acridone (Figure 6A), which is a
hydrolysis product ofDAPA (Figure 2). Only very slow hydrolysis
British Journal ofCancer(1997) 76(7), 894-903 0 Cancer Research Campaign 1997898 KO Hicks etal
A
Figure 4 (A) Sensitivity analysis of flux experiments. Flux curves were simulated, using the model of Appendix 1 without binding, for addition of the diffusant to
compartment 1 at zero time (thereafter unstirred) and with compartment 2 well stirred. The ordinate is the concentration in compartment 2 as a fraction of that at
infinite time for the values of DMM shown in the figure, assuming D1 = 10-5 cm2 S-1, MM thickness = 200 gm, path length in compartment 1 = 6.6 mm and volume
of compartment 2 = 18 ml (equivalent path length 230 mm). Solid lines: with support membrane (thickness 30 ,um, porosity 7.3%). Dashed lines: without support
membrane. (B) Flux of [14C]urea through collagen-coated Biopore support membranes without cells (filled symbols; c,10 245 gM, agar concentration 0 (-), 0.5%
(0), 1% (A) or 2% (V) and with V79-171b MM (open symbols; c,,0 86 gM, agar concentration 0.5%). Curves were fitted using the diffusion model without binding
(Appendix 1), with D, as the fitted parameter in the absence of cells and DMM as the fitted parameter in the presence of cells
to acridone (0.3 % per h) was detected in medium under these
conditions (data not shown). The ratio of DAPA to acridone
increased with time (Figure 6B), demonstrating that the high ratio
ofacridone to DAPA in compartment 2 results mainly from enrich-
ment of the pre-existing acridone impurity due to its rapid diffu-
sion through the MM.
The concentrations of DAPA in compartment 2, shown in
Figure 5, have been corrected for the acridone contaminant using
the data ofFigure 6B. In the experiments with MM, [14C]urea was
added to compartment 1 at the same time as [3H]DAPA (using a
'4C/3H d.p.m. ratio of 0.1) to provide an internal standard.
The effective thickness of each MM, which ranged from 210
to 260 gm, was estimated from the urea flux data using D1 =
1.6 x 10-5 and DMM = 1.45 x J06 Cm2 S'1.
Flux of DAPA through V79-171b MM was dramatically slower
than through the support membrane alone, with an estimated initial
DMM of c. 1.3 x 10-8 cm2 s-' (over the range 0-5 h), i.e. approxi-
mately 300 times lower than in medium. However, the shape ofthe
flux curve was not consistent with the simple diffusion model (i.e.
assuming a constant DMM). Rather, the time-dependent increase in
flux suggested a slow approach to steady state, as would occur if
there were a high DAPA-binding capacity within the MM. The
possibility that this binding is in part due to sequestration in acidic
endosomes was tested by addition of the lysosomotropic base
ammonium chloride (50 mM) to both compartments. This selec-
tively enhanced flux of DAPA relative to acridone (Figure 6B),
and resulted in a large increase in DAPA flux relative to that
without ammonium chloride (Figure 5). Ammonium chloride had
no effect on flux of the [14C]urea internal standard (data not
shown), indicating that it was not cytotoxic under these conditions.
Cellular uptake of DAPA, and its relationship to
diffusion in multicellular membranes
Fluorescence microscopy of V79-171b cells exposed to DAPA
while growing on glass coverslips showed a pattern of subcellular
distribution consistent with localization in endosomes (Figure 7A).
This localization was inhibited by ammonium chloride (50 mM),
resulting in diffuse cytoplasmic fluorescence (Figure 7B).
Lowering of pH from 7.4 to 6.5 decreased overall fluorescence
intensity without preventing localization in vesicles (Figure 7C). A
quantitative examination of uptake of [3H]DAPA into V79-171b
cells, in single cell suspensions freshly isolated from MM, showed
that high ratios ofintracellular to extracellular drug were achieved
rapidly (c. 150-fold by 5 min) at pH 7.2, and that this ratio then
increased slowly (Figure 8). Ammonium chloride inhibited this
second (slow uptake) component whereas at pH 6.5 uptake was
suppressed strongly at all times. The lines in Figure 8 are the fits to
an empirical model, in which uptake is driven by binding to
saturable and non-saturable intracellular sites (Appendix 2).
Thebinding parameters fromthe single cell uptake study (Table 1)
were used to represent DAPA binding in V79-171b MM in a flux
model based on a reaction-diffusion equation (Appendix 1). In this
pre-steady state treatment it was assumed that the MM is a homo-
geneous compartment through which reaction (binding) and diffu-
sion occur simultaneously. The binding parameters from the single
cell experiments at pH 7.2 (Table 1) were used as this value is
intermediate between the measured average pH in compartments 1
(pH 7.0) and 2 (pH 7.47). The binding parameters were adjusted for
the higher cell density in the MM (2.9 x 108 cells ml-', estimated
from the cell yield of 5 x 106 per MM after pronase digestion and
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Figure 5 Flux of [3H]DAPA through collagen-coated support membranes
without cells (0, 0.5% agar; *, 1% agar; A, 2% agar in compartment 1, c1 0
24 gM) and with V79-171b MM using agar at 0.5% in compartment 1 (0, c;,O
16 gM; LI, C10 36 rM). DAPA flux through MM was also investigated with
50 mM ammonium chloride in both compartments (A, c, 0 16 gM).
Representative curves only are shown for clarity. For the cell-free data the
curves are fits for diffusion without binding, with D, as the fitted parameter.
For the MM data, the full reaction-diffusion model (Appendix 1) was used as
described in the text
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the total MM volume calculated from its mean thickness). The
MM thickness estimated from the internal standard (urea) flux
kinetics was used in each case, and the fitted parameter in the reac-
tion-diffusion model was the DMM for free DAPA. This model
gave good fits to the DAPA flux data (Figure 5), yielding mean
estimates ofDMM forfree DAPA of4.8 ± 0.3 (s.e.m.) x 10-7 Cm2 S-1
(n = 9) without ammonium chloride and 5.0 ± 0.7 x 10-7 Cm2 S-1
(n = 4) with ammonium chloride. This indicates that the diffusion
coefficient ofDAPA in the MM (when known binding in cells has
been accounted for) is approximately eightfold less than in
medium, and that the effect of ammonium chloride on flux can be
accounted for by its effect on cellular uptake/binding in single cell
suspensions.
DISCUSSION
The growth oftumour cells as a multicellular layer provides a new
in vitro model for the extravascular compartment oftumours. This
model can be considered an extension of the use of tumour cell
monolayers on microporous supports (Adson et al, 1994, 1995).
The latter have been investigated as models for endothelial or
epithelial absorption barriers but, being only one cell thick, do not
include the heterogeneous microenvironments that arise as a result
oflimiting transport ofnutrients, oxygen and waste products in the
extravascular compartment oftumours. In contrast MMs are diffu-
sion-limited structures, as demonstrated by necrosis in regions
distant from the nutrient source and the presence of radiobiologi-
cally hypoxic cells (Cowan et al, 1996), and by the accumulation
of cells with a GI-phase DNA content (data not shown). In these
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Figure 6 (A) HPLC radiochromatogram for a sample taken from compartment 2 at 7.5 h during a [3H]DAPA flux experiment, using a V79-171b MM (c1,o 16 gM).
(B) The fraction of total radioactivity in compartment 2 due to DAPA for the experiment shown in Figure 3. 0: c, 0 16 ,UM, without ammonium chloride. 0li: c1 0
36 ,UM, without ammonium chloride. A: c1,O 16 gM with 50 mm ammonium chloride.
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Figure 7 Fluorescence microscopy of V79-171b cells, grown on glass coverslips, after incubation with DAPA (50 ,UM) for 10 min. (A) pH 7.4. (B) pH 7.4 with
ammonium chloride (50 mM). (C) pH 6.5. The bar represents 10,um
0 10 20 30 40 50 60
Time (min)
Figure 8 Representative data showing kinetics of uptake of [3H]DAPA by
single-cell suspensions (5 x 105 cells ml-1), obtained from V79-171b MM,
after adding DAPA (ca 15 gM) at extracellular pH values of 7.6 (V, V), 7.2
(0, 0) and 6.7 (N, Li). Closed symbols, without ammonium chloride; open
symbols, with ammonium chloride. Mean intracellular concentrations were
calculated assuming a water volume of 1 pi per cell. The curves are extended
least square fits for the uptake model described in Appendix 2.
respects MMs closely resemble multicellular spheroids, and
other diffusion-limited multicellular systems such as histocultures
(Hoffman, 1991) and hollow fibre cultures (Casciari et al, 1994),
but offer the important advantage that diffusion of substances can
be examined in a direct way by measuring flux across the struc-
ture. The MM model is thus ideally suited to examining the
extravascular transport characteristics oftherapeutic agents, nutri-
ents and macromolecules such as cytokines and growth factors.
Initial studies (data not shown) suggest that a variety ofrodent and
human tumour cell lines can be grown in this manner, and that
some cell lines that do not form spheroids efficiently grow well as
MM. Thus, this model may find avariety ofapplications in tumour
biology. A similar model has recently been developed by
Minchinton et al (1997).
Table 1 Parameters used to fit the flux of [3H]DAPA through V79-171b MM,
using the diffusion-with-binding model (Appendix 1)
Model parameters
Length of compartment 1 6.6 mm
Thickness of MMa 235 ± 15 gm
Thickness of support membrane 30,m
Porosity of support membrane 7.3%
DJ (Cm2 S-1) X 106 3.87 ± 0.28
Cell density in MM 2.9 x 108 ml-'
Transport parameters in the MM No NH4CI 50 mm NH4CI
k1b (s-') 24.9 24.9
k1b(s-l) 1.17 1.17
k2b (s-' AM-') 0.0018 0
k_2b (S-1) 0.036 0
BEab (gM) 2382 0
Fifted DMM for free DAPA (cm2 s-1) x 107 4.8 +0.3 5.0 + 0.7
a Determined from urea flux kinetics, using DMM = 1.45 x 10-6 cm2 s-'.
b Determined from the single cell uptake kinetics at pH 7.2 (Figure 8). Values
for k, and Bm,, are scaled to the cell density in the MM.
The method for measuring flux across MMs described here
(with compartment 1 unstirred after addition of diffusant) is
convenient, but will be less sensitive to the impediment imposed
by the cellular barrier than if both sides are stirred. Nonetheless,
numerical simulation of flux showed that the model is suitably
sensitive to DMM, especially if the early flux kinetics is examined
(Figure 4A). Measured flux under these conditions is very sensi-
tive to any convective disturbance that collapses the concentration
gradient in compartment 1, but this problem was conveniently
overcome by addition of agar. This also ensured that there was no
bulk flow between compartments, which is particularly important
in measuring diffusion through the support membrane in the
absence of cells. The diffusion equation has no analytical solution
under these conditions, but is readily solved using numerical
methods.
The use ofthis method is illustrated by the investigation ofurea
diffusion. The flux data are well fitted by the simple Fickian diffu-
sion model, both in the presence and absence of the cellular layer
(Figure 4B). Good reproducibility is seen between replicate deter-
minations, and the estimated DMM is lower than that in medium
(compartment 1) by factors of 11 and 8 for V79-171b and
EMT6/Ak MM respectively. The flux of urea in this system is
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clearly faster than that across well-differentiated colon carcinoma
(Caco-2) cell monolayers (Adson et al, 1994), although the latter
are only c. 10 ,um in thickness. The flux ofthis hydrophilic solute
appears to be primarily through a paracellular (between cells)
pathway in the latter epithelial model, but a contribution from the
transcellular (through cells) pathway cannot be ruled out in V79-
171b and EMT6/Ak MM.
The very slow flux of DAPA through MM shows that the MM
imposes a much more severe impediment to diffusion of this
compound. A complication in investigating the diffusion of
[3H]DAPA is that the flux is dominated at early times by a minor
radioactive and fluorescent hydrolysis product, acridone, that
diffuses much more rapidly than the parent compound (Figure 6).
This would lead to overestimation of DAPA diffusion rates as
measured by autoradiography or fluorescence microscopy, tech-
niques which are often used to examine diffusion in multicellular
spheroids or tumour tissue. A key advantage of the MM model is
that it allows use ofcompound-specific analytical methods such as
HPLC to identify the diffusing species.
The shape of the flux curve for DAPA could not be described
adequately by simple diffusion under steady state conditions (i.e.
by assuming a constant effective diffusion coefficient in the MM).
The increasing flux with time strongly suggests that the approach
to steady state is slow because of a large DAPA-binding capacity
in the MM. Such binding might be due to DNA intercalation or
other macromolecular binding, but any other reversible entrap-
ment in cells (e.g. active transport, or sequestration of this basic
acridine in acidic vesicles driven by pH gradients) would have an
analogous effect on flux. The large increase in DAPA flux caused
by co-incubation with ammonium chloride (Figure 5) at concen-
trations known to raise lysosomal pH (Siim et al, 1994) point to
sequestration in acidic vesicles as the major impediment to diffu-
sion. Such entrapment in cells was demonstrated by fluorescence
microscopy, which showed intense DAPA fluorescence in cyto-
plasmic vesicles and confirmed that uptake into these vesicles is
inhibited by ammonium chloride (Figure 7).
A full spatially distributed model of the effects of lysosomal
sequestration on net flux would require detailed information on
diffusion coefficients in the extracellular, cytoplasmic and lyso-
somal compartments, and the transmembrane exchange kinetics
and topographical relationships between these compartments. A
practical altemative is to approximate the cellular entrapment as
reversible binding to sites distributed isotropically within a homo-
geneous MM. Such lumped parameter modelling ofthe flux under
pre-steady state conditions (Appendix 1) indicated that models of
this type could describe the observed flux well. However, within
the precision of the data an envelope of solutions was possible,
with a wide variety of values for the binding site concentration,
reaction (association and dissociation) rate constants, and the
diffusion coefficient of the free drug (data not shown). We there-
fore sought to constrain the model by providing independent
estimates of the intracellular binding parameters.
Sequestration of [3H]DAPA by V79-171b cells was fitted well
by a simple binding model (Figure 8 and Appendix 2). The intra-
cellularbinding parameters determined for single-cell suspensions
(after scaling k1 andBmax appropriately to allow for the difference
in cell density) were applied to the reaction-diffusion model for
DAPA flux in V79-171b MM. With theDMM offree DAPA now as
the only fitted parameter, this model gave an excellent fit both with
and without ammonium chloride (Figure 5). The fitted value of
DMM was unaffected by ammonium chloride (i.e. the effect of
ammonium chloride is entirely accounted for by its effect on
uptake into cells), which gives further support to the model. The
value for DMM for free DAPA, eightfold lower than in medium,
also appears to be a reasonable estimate for the tissue diffusion
coefficient ofthe free drug as theDMM for urea (this study) and for
misonidazole (Cowan et al, 1996) are lower than that in medium
by 11- to 12-fold. The high microviscosity of cytoplasm gives
diffusion coefficients for (unbound) small ions and non-elec-
trolytes two- to fivefold lower than in water (Mastro and Keith,
1984), but membrane barriers impose an additional two- to five-
fold reduction in transcellular diffusion for dyes with MW similar
to DAPA (Safranyos et al, 1987).
Although the fit of the DAPA flux to the reaction-diffusion
model is impressive, this treatment should be considered illustra-
tive of the potential of the approach, rather than providing defini-
tive transport parameters, as the gradients of extracellular and
intracellular pH through the MM have not yet been determined,
and the binding rate constants describing cell uptake are very
sensitive to pH (Figure 8), as expected for this diprotic base. The
flux model used for Figure 5 assumes a single value of7.2 for the
extracellularpH throughout the MM. The fit to the model was less
satisfactory when the binding parameters for pH 6.7 or 7.6 were
used, indicating that the estimate of pH 7.2 may be reasonable.
This is also supported by microelectrode data showing a pH
gradient from 7.4 to 7.1 through the viable rim of V79-379A
spheroids (Carlsson and Acker, 1988). The other parameters not
defined with precision are the intracellular volume fraction in the
MM, the fraction of necrotic tissue, and the distribution of thick-
nesses for each MM. A fully quantitative treatment will require
improved (preferably non-destructive) methods for monitoring
these parameters.
Although the individual transport parameters for DAPA in V79-
171b MM (Table 1) are provisional, together they provide a good
empirical model for flux through the MM and thus allow for the
first time an estimate of the diffusion time of a cytotoxic drug in
the extravascular compartment of tumours based on pre-steady
state measurements in an experimental model. The reaction-
diffusion model (Appendix 1) was used to calculate diffusion
times, assuming a simple planar geometry to provide an approxi-
mate estimate. The time required for this DNA intercalator to
reach a free drug concentration 90% ofthat in plasma at a distance
of 100gMinto an extravascularcompartment is 13 h. Although the
pharmacokinetics of this model compound has not been investi-
gated, the required diffusion time will be much longer than the
plasma half life, and slow extravascular transport will therefore
compromise delivery to cells distant from functional blood vessels.
The impediment to diffusion in tissue imposed by DNA binding
of drugs is well recognized, but almost all drugs that bind physi-
cally to DNA are also bases, and therefore prone to sequestration
in lysosomes. The implications of lysosomal uptake (which is
formally analogous to the DNA binding problem) for extravas-
cular drug transport have received less consideration. The use of
lysosomotropic bases such as chloroquine may be of interest as a
means of overcoming this restriction. We are also investigating
prodrug approaches, such as tertiary amine N-oxide derivatives of
basic DNA intercalators (Wilson et al, 1996), as strategies for
enhancing drug delivery. Such prodrugs have the potential for
bioreductive release of the active intercalators in hypoxic regions
of tumours. The present MM model will be a valuable tool for
investigating extravascular transport of these prodrugs and their
DNA-binding products.
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APPENDIX 1: DIFFUSION WITH REACTION IN
MULTICELLULAR MEMBRANES
Drug diffusion in each of three or four compartments in series
(compartment 1, MM if present, support membrane and compart-
ment 2) was modelled assuming each to be a homogeneous phase
in which binding to saturable and non-saturable sites can occur,
and that the bound drug is immobile. The equations for this
reaction-diffusion model are:
acf a2c
-= D aX2-kc +kICbI-k2Cf(B -CO) +ksCb aJt
f mx2b
ac
a-=klcf
-
acb
at k2cf (Bmax-Cb)- k-2Cb2
where c5, Cbl, Cb2 are the concentrations of free drug, drug bound to
the non-saturable sites and to the saturable sites respectively, at posi-
tion x and time t; Df is the diffusion coefficient of the free drug; k,
and k, are the forward (association) and reverse (dissociation) rate
constants, respectively, for non-saturable binding; k2 and k 2 are the
forward and reverse rate constants, respectively, for saturable
binding; Bmax is the total concentration of saturable binding sites. In
the absence ofbinding (i.e. k, =k = 2= =0), thereaction-diffu-
sion equations reduce to Fick's second law. The boundary conditions
are for zero flux at the upper surface of compartment 1 (x = 0) and
the lower surface ofcompartment 2 (x = B),
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ac
x=O, atx=O,x=B, t>0
and initial conditions Cf (X,O) = C1l0 in compartment 1, cf(x,O) = 0
otherwise, and cbl (x,O) = cb2(x,O) = 0 in all compartments.
The parameters take on different values in each compartment.
The values of the binding parameters for the MM compartment
were obtained experimentally from the kinetics of binding to
single cells (Appendix 2). In both the MM and single-cell systems,
the binding sites are intracellular but are averaged over the whole
volume. The values of k, (proportional to the non-saturable
binding site concentration) and Bmax obtained from the single cell
data were therefore multiplied by the ratio of cell densities in the
MM and single cell system (see Results).
The system ofpartial differential equations for diffusion through
all compartments was solved numerically using a finite difference
method in the NAG Library routine DO3PBF, on a VAX 11/750
minicomputer. The predicted compartment 2 concentration-time
curve was fitted to the data using the diffusion coefficient for free
drug in one of the compartments (i.e. D,, DMM or DS) as the fitted
parameter, with minimization of the sum of squared deviations as
the fitting criterion. D2 was set at 1000 cm2 s-1 to model continuous
stirring in compartment 2. The software was validated by calcu-
lating the concentration-time profile at a distance of0.5 cm from a
plane boundary between two unstirred compartments with lengths
of 0.5 cm (D = 10(- cm2 S-'; C(X,O) = 10 gM for 0 < x <0.5 and
c(x,0)=0 for 0.5 <x < 1). The calculated concentrations were within
1% ofthe analytical solution (Crank, 1975) at all times after 10 min.
APPENDIX 2: KINETICS OF DRUG UPTAKE
MODELLED AS INTRACELLULAR BINDING
The uptake of DAPA by single cells was also treated as a homo-
geneous binding problem to make the mathematical formalism
compatible with the reaction-diffusion model above. In this
approach cellular uptake was assumed to be due to reversible
intracellular binding alone (which, using a continuum approxima-
tion, is mathematically equivalent to reversible sequestration into
subcellular vesicles). In this case the extracellular drug concentra-
tion (ce) can be considered a measure of the concentration (Cf) of
the free drug, and the total intracellular concentration, c, is equal
to total intracellular bound and free drug.
Experiments examining c; as a function of ce (data not shown)
were compatible with a high-affinity saturable binding mode plus
a non-saturable low-affinity mode. A model consisting of two
classes of intracellular binding sites was also necessary to
adequately describe the kinetics of DAPA binding by single V79-
17lb cells (Figure 8).
The equations describing the cellular binding model are:
dc
dt k1cf-k-ICbl
dc
dt k2Cf (Bmax- Cb2)-k 2cb2
Cellularbinding caused loss ofdrug from the medium and hence Cf
decreased according to:
Cf Co- cb1 bCb2
The initial conditions are Cf= C0, the initial concentration ofdrug in
the extracellular medium, and Cb,= Cb2 = 0.
The model predictions for ce and c; were fitted to the measured
values from the uptake experiments using the programme
MKModel, with k1, k l, k2, k 2, and Bmax as fitted parameters. The
differential equation solver in MKModel uses a 4th order
Range-Kutta method with minimization of the extended least
squares function (Peck et al, 1984) as fitting criterion. The data
were fitted to pairs of curves at the same pH, assuming that the
saturable binding component was eliminated (k2 = k 2 = Bmax =0)
in the presence ofammonium chloride.
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